1 / 9

Charcot Marie Tooth Market

It is a disease of the peripheral nerves that control muscles (unlike the muscular dystrophies, which affect the muscles themselves).<br>

DelveInsight
Download Presentation

Charcot Marie Tooth Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Charcot Marie Tooth Disease (CMT) 01 It is a disease of the peripheral nerves that control muscles (unlike the muscular dystrophies, which affect the muscles themselves). 02 It is a group of heterogeneous disorders which affect the motor and sensory peripheral nerves, resulting in muscle weakness and atrophy. 03 CMT types are distinguished by age of onset, inheritance pattern, severity, and whether they are linked to defects in axon or myelin. 04 CMT types are CMT1, CMT2, CMT3, and CMT4. They are major types of CMT associated with a large number of subtypes. 05 CMT symptoms are muscle weakness, contractures and bone deformities, sensory loss and associated symptoms. • DelveInsight © 2019 | All rights reserved

  2. CMT Epidemiology • Charcot Marie Tooth total diagnosed prevalent population in 7 major markets (7MM)* was 3,878 cases in 2017. •An estimated 150,000 people was affected in the United States. • Among the European countries, France had the highest CMT diagnosed prevalent population with 272 cases, followed by the United Kingdom, which had CMT diagnosed prevalent population of 228 in 2017. Whereas Spain had the lowest diagnosed prevalent population of 84 in 2017. •Japan had 73 diagnosed prevalent cases of Charcot Marie Tooth in 2017. * 7MM- USA, EU-5(Germany, Spain, Italy, France and UK), Japan • DelveInsight © 2019 | All rights reserved

  3. CMT Market Outlook Despite the fact that there is no currently approved therapies for CMT treatment and that CMT market is entirely dependent on off-label therapies and procedural management, companies have not yet shifted their focus towards this therapeutic area. The United States had the highest Charcot Marie Tooth market size in 2017that accounts for approximately 47% of the total market. Overall, the increasing CMT prevalence, awareness and emerging CMT pipeline therapies will propel CMT market size forward during the forecasted period. Spain accounted for the least Charcot Marie Tooth market share (8.62%) among the 7MM countries. • DelveInsight © 2019 | All rights reserved

  4. CMT Emerging Therapies and Companies 01 Drug- PXT3003 Company- Pharnext 02 Drug- MD1003 Company- MedDayPharmaceuticals 03 Drug- ACE-083 Company- Acceleron • DelveInsight © 2019 | All rights reserved

  5. Complete Information For complete information on Charcot Marie Tooth (CMT) Market Insights, Epidemiology and Market Forecast - 2027 please click the link below CLICK HERE OR Write Us At  info@delveinsight.com • DelveInsight © 2019 | All rights reserved

  6. About DelveInsight 2 1 3 Mission About To provide “insights across the value chain” and helping the organization to take a prudent business decision through the use and analysis of actionable market intelligence. The mission also is to provide the most effective result and efficient service with utmost client care for maintaining a long-term relationship with them. Vision DelveInsight is a premier Business Consulting and Market Research firm focused exclusively on the life science segment. With a wide array of smart end-to-end solutions, the firm helps the global Pharmaceutical and Bio-Tech companies formulate prudent business decisions for improving their performances to stay ahead of the competitors. To be the most trusted market research & business consulting firm in the world; and to continue enable the Pharma & Bio-Tech companies to achieve their goals with the best strategic insight and competitive solution. The vision also is inclusive of becoming a one-stop solution provider for the entire gamut of drug development process. • DelveInsight © 2019 | All rights reserved

  7. Services by DelveInsight 8 7 2 1 3 5 4 6 Market Intelligence Opportunity Assessment Forecasting PharmDelve Competitive Analysis Pipeline Consulting Report Store • DelveInsight © 2019 | All rights reserved

  8. Contact Us info@delveinsight.com +91-11-4568 9769 www.delveinsight.com blog/delveInsight/ twitter/delveInsight LinkedIn/delveInsight • DelveInsight © 2019 | All rights reserved

More Related